Literature DB >> 27749053

Sulfamide as Zinc Binding Motif in Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa).

Nis Halland1, Jörg Czech1, Werngard Czechtizky1, Andreas Evers1, Markus Follmann1, Markus Kohlmann1, Herman A Schreuder1, Christopher Kallus1.   

Abstract

Previously disclosed TAFIa inhibitors having a urea zinc-binding motif were used as the starting point for the development of a novel class of highly potent inhibitors having a sulfamide zinc-binding motif. High-resolution X-ray cocrystal structures were used to optimize the structures and reveal a highly unusual sulfamide configuration. A selected sulfamide was profiled in vitro and in vivo and displayed a promising ADMET profile.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27749053     DOI: 10.1021/acs.jmedchem.6b01276

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

Review 1.  Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?

Authors:  Karen Claesen; Joachim C Mertens; Dorien Leenaerts; Dirk Hendriks
Journal:  Int J Mol Sci       Date:  2021-01-17       Impact factor: 5.923

Review 2.  Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review.

Authors:  Machteld Sillen; Paul J Declerck
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

3.  Synthesis, in silico study (DFT, ADMET) and crystal structure of novel sulfamoyloxy-oxazolidinones: Interaction with SARS-CoV-2.

Authors:  Abdeslem Bouzina; Malika Berredjem; Sofiane Bouacida; Khaldoun Bachari; Christelle Marminon; Marc Le Borgne; Zouhair Bouaziz; Yousra Ouafa Bouone
Journal:  J Mol Struct       Date:  2022-02-05       Impact factor: 3.841

4.  Conformational Consequences for Compatible Osmolytes on Thermal Denaturation.

Authors:  Nimesh Shukla; Brianna Bembenek; Erika A Taylor; Christina M Othon
Journal:  Life (Basel)       Date:  2021-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.